Archive · 19 Jan 2026
Niner Pharmaceuticals Expands into Peptides and AI
Niner Pharmaceuticals, a healthcare company, is expanding into making special molecules called peptides to help with health and longevity.
They are also working on a smart home system called Ambientera, which uses AI to make homes safer and more aware of people's needs.
The company wants to use technology to help prevent health problems before they start.
Ambientera is being developed in India and will be available worldwide next year for luxury homes, elder care, and smart cities.
The CEO, Jamie Balaji Rao, believes this will change how healthcare and homes work together.
Niner Pharmaceuticals is expanding into high-purity peptides for metabolic health and longevity.
The company is developing Ambientera, an AI-driven home solution for residential intelligence.
Ambientera aims to introduce context awareness, governance, and safety intelligence to homes.
The platform is being developed in India and will target global markets next year.
Niner Pharmaceuticals is integrating AI to enable predictive and personalized wellness pathways.
- Who
- Niner Pharmaceuticals LLC
- What
- Expansion into high-purity peptides and AI-driven home solution (Ambientera)
- When
- Development ongoing, launch expected next year
- Where
- Headquartered in Hyderabad, India; targeting global markets
- Why
- To bridge molecular science with patient outcomes and create intelligent residential environments
- Company
- Niner Pharmaceuticals LLC
- New Focus
- High-purity peptides for metabolic health
- AI Project
- Ambientera (residential operating system)
- CEO
- Jamie Balaji Rao
- Development Location
- India
- Target Markets
- Global (luxury residential, elder-care, smart cities)
- Expected Launch
- Next year